Halozyme Therapeutics Inc (NASDAQ:HALO)

During the Trading Day
15.39 -0.31 / -1.97%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
15.30 -0.09 / -0.58%
 
Volume: 40.2K

Today’s Trading

Previous close15.70
Today’s open15.70
Day’s range15.21 - 15.89
Volume1,927,318
Average volume (3 months)1,941,110
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 03/05/2015

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+19.60%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc+0.11+1.25%
OPHTOphthotech Corp-0.43-0.80%
RLYPRelypsa Inc+1.71+4.28%
RDUSRadius Health Inc+2.04+4.62%
Data as of 4:00pm ET, 03/05/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account